SCHEMBL24427982

SCHEMBL24427982

CC(C)(C)OC(=O)Nc1ccc(Br)c(F)c1Cl

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP17A1 P05093 1/20 0.40
▸ ATR Q13535 1/20 0.39
▸ KCNQ4 P56696 3/20 0.38
▸ KCNQ5 Q9NR82 3/20 0.38
▸ NPC1 O15118 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ SSTR4 P31391 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ AAK1 Q2M2I8 4/20 0.36
▸ RECQL P46063 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30126132 0.89 CYP17A1 (0.40) CYP17A1ATRKCNQ4KCNQ5NPC1
SCHEMBL24427976 0.87 CYP17A1 (0.42) CYP17A1KCNQ4KCNQ5NPC1RAB9A
SCHEMBL30038713 0.84 CYP17A1 (0.40) CYP17A1ATRKCNQ4KCNQ5NPC1
SCHEMBL28459659 0.84 CYP17A1 (0.40) CYP17A1ATRKCNQ4KCNQ5NPC1
SCHEMBL28458867 0.83 KCNQ3 (0.41) CYP17A1KCNQ4KCNQ5NPC1RAB9A
SCHEMBL34473354 0.82 ATR (0.40) CYP17A1ATRNPC1RAB9AMEN1
SCHEMBL21468506 0.82 KCNQ4 (0.40) CYP17A1ATRKCNQ4KCNQ5NPC1
SCHEMBL3288639 0.81 CYP17A1 (0.44) CYP17A1ATRKCNQ4KCNQ5RXFP1
SCHEMBL22684078 0.81 CYP17A1 (0.38) CYP17A1KCNQ4KCNQ5NPC1RAB9A
SCHEMBL24427983 0.80 KCNQ4 (0.38) CYP17A1ATRKCNQ4KCNQ5NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3998263-A1 TRICYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Jemincare Pharmaceuticals Co., Ltd. (CN) 2022-05-18 — — EP disclosed
Send feedback